David Lawrence, IAS 2021: Liposomal Amphotericin B Deoxycholate for the treatment of HIV-associated Cryptococcal Meningitis
We had the pleasure to meet with David Lawrence (London School of Hygiene and Tropical Medicine, London, UK) to discuss single high-dose liposomal amphotericin based regimen for treatment of HIV-associated Cryptococcal Meningitis.
The abstract entitled: ‘Single high-dose liposomal amphotericin based regimen for treatment of HIV-associated Cryptococcal Meningitis: results of the phase-3 Ambition-cm Randomised Trial’ was presented at IAS 2021 – the 11th International AIDS Society Conference on HIV Science (Virtual).
- Could you tell us a little about HIV-associated cryptococcal meningitis (CM), and its health burden in sub-Saharan Africa? (0:20)
- What treatment options are recommended for CM and what are their limitations? (0:41)
- What is the rationale for the use of a single, high-dose of liposomal amphotericin B deoxycholate in this treatment setting? (2:08)
Disclosures: David Lawrence has nothing to disclose in relation to this video.
Support: Interview and filming supported by Touch Medical Media. Interview conducted by Katey Gabrysch.
Filmed in coverage of IAS 2021 Virtual.
Share this Video
Related Videos In Bacterial Infections
Kayla Stover Hielscher, IDWeek 2022: Ceftriaxone as a treatment option for MSSA, ensuring optimum activity
Ceftriaxone is frequently used to treat methicillin-susceptible Staphylococcus aureus (MSSA). In this touchINFECTIOUS DISEASES interview, we met with Prof. Kayla Stover Hielscher (University of Mississippi School of Pharmacy, Jackson, MS, USA) to discuss advantages and limitations of the use of ceftriaxone for the treatment of MSSA, and the data that exists to support its use […]
Kayla Stover Hielscher, IDWeek 2022: Linezolid as a treatment option for MRSA bacteraemia
Methicillin-resistant Staphylococcus aureus (MRSA) bacteraemia is one of the more severe forms of MRSA. In this touchINFECTIOUS DISEASES interview, we met with Prof. Kayla Stover Hielscher (University of Mississippi School of Pharmacy, Jackson, MS, USA) to discuss the use of linezolid as a treatment option for MRSA bacteraemia infection. Dr Stover Hielscher discusses drug interactions, […]
Michael Ison: Highlights from IDWeek 2022
In this touchINFECTIOUS DISEASES interview, we met with Prof. Michael Ison (Northwestern University Feinberg School of Medicine, Chicago, IL, USA) to discuss his highlights from IDWeek 2022. He highlights vaccine development applied outside of COVID-19, and transformational RSV vaccines, antivirals, antifungals and antibiotics. Interviews available in this series: Respiratory syncytial virus (RSV) – Health burden […]
Journal articles and more to your inbox
Get the latest clinical insights from touchINFECTIOUS DISEASESSign me up!